Associate Professor Arutha Kulasinghe with advanced spatial biology maps that identify molecular fingerprints predicting how non-small cell lung cancer responds to immunotherapy — a breakthrough that could personalise treatment and spare patients ineffective therapies. Source: Supplied / Photo by Lyndon Mechielsen. Copyright to Wesley Research Institute and Lyndon Mechielsen.
Associate Professor Arutha Kulasinghe, Wesley Research Institute, whose Nature Genetics–published research has identified a molecular fingerprint that can predict which non-small cell lung cancer patients are likely to benefit from immunotherapy, using advanced imaging and artificial intelligence. Source: Supplied / Lyndon Mechielsen/Wesley Research Institute.
